The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.
Novartis snaps up rare disease biotech DTx Pharma in $1bn deal –
DTx Pharma’s Charcot-Marie-Tooth therapy candidate was able to induce remyelination of axons. Axons in patients with type 1 of the disease have myelin abnormalities. Image